HUP0000987A3 - Substituted isoquinoline derivatives and their use as anticonvulsants - Google Patents

Substituted isoquinoline derivatives and their use as anticonvulsants

Info

Publication number: HUP0000987A3
Authority: HU; Hungary
Prior art keywords: anticonvulsants; isoquinoline derivatives; substituted isoquinoline; substituted; derivatives
Prior art date: 1997-12-17

Application number

HU0000987A

Other languages

English (en)

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-17

Filing date

1998-03-16

Publication date

2000-10-30

1998-03-16 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1998-03-16 Priority claimed from PCT/GB1998/000782 external-priority patent/WO1998041508A1/en

2000-09-28 Publication of HUP0000987A2 publication Critical patent/HUP0000987A2/hu

2000-10-30 Publication of HUP0000987A3 publication Critical patent/HUP0000987A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Psychology (AREA)
Addiction (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)

HU0000987A 1997-12-17 1998-03-16 Substituted isoquinoline derivatives and their use as anticonvulsants HUP0000987A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9726695.1A GB9726695D0 (en)	1997-12-17	1997-12-17	Novel compounds
PCT/GB1998/000782 WO1998041508A1 (en)	1997-03-18	1998-03-16	Substituted isoquinoline derivatives and their use as anticonvulsants

Publications (2)

Publication Number	Publication Date
HUP0000987A2 HUP0000987A2 (hu)	2000-09-28
HUP0000987A3 true HUP0000987A3 (en)	2000-10-30

Family

ID=10823780

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HU0000987A HUP0000987A3 (en)	1997-12-17	1998-03-16	Substituted isoquinoline derivatives and their use as anticonvulsants
HU0004663A HUP0004663A3 (en)	1997-12-17	1998-12-16	Substituted isoquinoline derivatives, process for producing them and use of them for producing pharmaceutical compositions as anticonvulsants and pharmaceutical compositions containing them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
HU0004663A HUP0004663A3 (en)	1997-12-17	1998-12-16	Substituted isoquinoline derivatives, process for producing them and use of them for producing pharmaceutical compositions as anticonvulsants and pharmaceutical compositions containing them

Country Status (30)

Country	Link
US (1)	US6248754B1 (hu)
EP (1)	EP1042296B1 (hu)
JP (1)	JP2002508360A (hu)
KR (1)	KR20010033194A (hu)
CN (1)	CN1125052C (hu)
AP (1)	AP2000001832A0 (hu)
AR (1)	AR014942A1 (hu)
AT (1)	ATE260258T1 (hu)
AU (1)	AU744451B2 (hu)
BG (1)	BG104607A (hu)
BR (1)	BR9813642A (hu)
CA (1)	CA2315079A1 (hu)
CO (1)	CO5080731A1 (hu)
DE (1)	DE69821988T2 (hu)
EA (1)	EA200000657A1 (hu)
ES (1)	ES2216333T3 (hu)
GB (1)	GB9726695D0 (hu)
HU (2)	HUP0000987A3 (hu)
ID (1)	ID24810A (hu)
IL (1)	IL136382A0 (hu)
MA (1)	MA26583A1 (hu)
NO (1)	NO315649B1 (hu)
NZ (1)	NZ504706A (hu)
OA (1)	OA11526A (hu)
PE (1)	PE20000006A1 (hu)
PL (1)	PL341222A1 (hu)
SK (1)	SK9142000A3 (hu)
TR (1)	TR200001791T2 (hu)
WO (1)	WO1999031068A1 (hu)
ZA (1)	ZA9811503B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010016657A1 (en) *	1997-03-18	2001-08-23	Smithkline Beecham P.L.C.	Substituted isoquinoline derivatives and their use as anticonvulsants
AU9512298A (en) *	1997-09-30	1999-04-23	Molecular Design International, Inc.	Beta3-adrenoreceptor agonists, agonist compositions and methods of using
GB9915589D0 (en) *	1999-07-02	1999-09-01	Smithkline Beecham Plc	Novel compounds
AU1734401A (en) *	1999-12-09	2001-06-18	Mitsubishi Pharma Corporation	Carboxyamido derivatives
US6593341B2 (en)	2001-03-29	2003-07-15	Molecular Design International, Inc.	β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
US7173032B2 (en)	2001-09-21	2007-02-06	Reddy Us Therapeutics, Inc.	Methods and compositions of novel triazine compounds
US6596734B1 (en)	2002-10-11	2003-07-22	Molecular Design International, Inc.	Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
US7119214B2 (en) *	2004-04-13	2006-10-10	Cephalon France	Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
GB0619176D0 (en) *	2006-09-29	2006-11-08	Lectus Therapeutics Ltd	Ion channel modulators & uses thereof
TWI459947B (zh)	2007-06-26	2014-11-11	Otsuka Pharma Co Ltd	苯并氮呯化合物及藥學製劑
CN118908892B (zh) *	2024-07-18	2025-10-31	武汉大学	氨基异喹啉类衍生物及其在制备抗病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4022900A (en) *	1970-09-09	1977-05-10	Marion Laboratories, Inc.	Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
TR199802745T2 (xx) *	1996-06-17	1999-04-21	Smithkline Beecham Plc	�kameli benzamid t�revleri ve bunlar�n ihtiya�lar� durdurucu veya engelleyici maddeler olarak kullan�lmas�.
BR9809047A (pt)	1997-03-18	2000-08-01	Smithkline Beecham Plc	Derivados de isoquinolina substituìda e o uso dos mesmos como anticonvulsivantes

1997
- 1997-12-17 GB GBGB9726695.1A patent/GB9726695D0/en not_active Ceased
1998
- 1998-03-16 HU HU0000987A patent/HUP0000987A3/hu unknown
- 1998-12-15 ZA ZA9811503A patent/ZA9811503B/xx unknown
- 1998-12-15 MA MA25393A patent/MA26583A1/fr unknown
- 1998-12-16 PL PL98341222A patent/PL341222A1/xx unknown
- 1998-12-16 TR TR2000/01791T patent/TR200001791T2/xx unknown
- 1998-12-16 CN CN98813570A patent/CN1125052C/zh not_active Expired - Fee Related
- 1998-12-16 WO PCT/GB1998/003785 patent/WO1999031068A1/en not_active Ceased
- 1998-12-16 KR KR1020007006579A patent/KR20010033194A/ko not_active Withdrawn
- 1998-12-16 JP JP2000538995A patent/JP2002508360A/ja active Pending
- 1998-12-16 EP EP98960040A patent/EP1042296B1/en not_active Expired - Lifetime
- 1998-12-16 EA EA200000657A patent/EA200000657A1/ru unknown
- 1998-12-16 ES ES98960040T patent/ES2216333T3/es not_active Expired - Lifetime
- 1998-12-16 DE DE69821988T patent/DE69821988T2/de not_active Expired - Fee Related
- 1998-12-16 ID IDW20001157A patent/ID24810A/id unknown
- 1998-12-16 PE PE1998001234A patent/PE20000006A1/es not_active Application Discontinuation
- 1998-12-16 AR ARP980106398A patent/AR014942A1/es not_active Application Discontinuation
- 1998-12-16 OA OA1200000180A patent/OA11526A/en unknown
- 1998-12-16 BR BR9813642-9A patent/BR9813642A/pt not_active Application Discontinuation
- 1998-12-16 CA CA002315079A patent/CA2315079A1/en not_active Abandoned
- 1998-12-16 NZ NZ504706A patent/NZ504706A/xx unknown
- 1998-12-16 AT AT98960040T patent/ATE260258T1/de not_active IP Right Cessation
- 1998-12-16 IL IL13638298A patent/IL136382A0/xx unknown
- 1998-12-16 SK SK914-2000A patent/SK9142000A3/sk unknown
- 1998-12-16 US US09/581,647 patent/US6248754B1/en not_active Expired - Fee Related
- 1998-12-16 AU AU15724/99A patent/AU744451B2/en not_active Ceased
- 1998-12-16 AP APAP/P/2000/001832A patent/AP2000001832A0/en unknown
- 1998-12-16 HU HU0004663A patent/HUP0004663A3/hu unknown
- 1998-12-17 CO CO98075174A patent/CO5080731A1/es unknown
2000
- 2000-06-16 NO NO20003142A patent/NO315649B1/no not_active IP Right Cessation
- 2000-07-13 BG BG104607A patent/BG104607A/bg unknown

Also Published As

Publication number	Publication date
HUP0000987A2 (hu)	2000-09-28
CN1125052C (zh)	2003-10-22
AP2000001832A0 (en)	2000-06-30
CO5080731A1 (es)	2001-09-25
EP1042296A1 (en)	2000-10-11
TR200001791T2 (tr)	2000-12-21
CA2315079A1 (en)	1999-06-24
EP1042296B1 (en)	2004-02-25
KR20010033194A (ko)	2001-04-25
PE20000006A1 (es)	2000-03-01
NO20003142L (no)	2000-06-16
HUP0004663A2 (hu)	2001-05-28
DE69821988D1 (de)	2004-04-01
NZ504706A (en)	2002-11-26
AU1572499A (en)	1999-07-05
MA26583A1 (fr)	2004-12-20
BR9813642A (pt)	2000-10-17
BG104607A (bg)	2001-02-28
GB9726695D0 (en)	1998-02-18
HUP0004663A3 (en)	2002-10-28
JP2002508360A (ja)	2002-03-19
ID24810A (id)	2000-08-24
SK9142000A3 (en)	2000-11-07
NO20003142D0 (no)	2000-06-16
ATE260258T1 (de)	2004-03-15
WO1999031068A1 (en)	1999-06-24
DE69821988T2 (de)	2005-01-05
IL136382A0 (en)	2001-06-14
CN1284946A (zh)	2001-02-21
ES2216333T3 (es)	2004-10-16
US6248754B1 (en)	2001-06-19
PL341222A1 (en)	2001-03-26
OA11526A (en)	2004-02-09
AU744451B2 (en)	2002-02-21
ZA9811503B (en)	2000-06-15
EA200000657A1 (ru)	2000-12-25
NO315649B1 (no)	2003-10-06
AR014942A1 (es)	2001-04-11

Publication	Publication Date	Title
EP1032377A4 (en)	2006-06-14	SUBSTITUTED 2-AMINOACETAMIDES AND APPLICATION THEREOF
IL126638A0 (en)	1999-08-17	Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
PL338357A1 (en)	2000-10-23	Some 5-alkyl-2-arylaminophenyloacetic acids and their derivatives
HUP0101172A3 (en)	2002-12-28	Ortho-anthranilamide derivatives and their use as anti-coagulants
EP1024130A4 (en)	2004-12-15	BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
HUP0001154A3 (en)	2001-06-28	3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same
ZA982478B (en)	1998-10-08	Compounds their use and preparation
IL131756A0 (en)	2001-03-19	Substituted isoquinoline derivatives and their use as anticonvulsants
NZ332757A (en)	1999-06-29	Substituted tetrahydroisoquinoline benzamide derivatives and their use as anticonvulsants and psycho-active agents
GB9702354D0 (en)	1997-03-26	Compounds and their use
PL332616A1 (en)	1999-10-25	Hydoxymethylhexanones as odorising and savourising agents
HUP0000987A3 (en)	2000-10-30	Substituted isoquinoline derivatives and their use as anticonvulsants
GB9704349D0 (en)	1997-04-23	Levobupivacaine and its use
IL135803A0 (en)	2001-05-20	Lipid mixtures and their use
HUP0104723A3 (en)	2004-10-28	New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
IL123535A0 (en)	1998-10-30	Benzoxazindione derivatives and their use
IL147103A0 (en)	2002-08-14	Substituted isoquinoline derivatives and their use as anticonvulsants
GB9704370D0 (en)	1997-04-23	Levobupivacaine and its use
PL341293A1 (en)	2001-04-09	Beta-lypothropin and application thereof
HK1032777A (en)	2001-08-03	Substituted isoquinoline derivatives and their use as anticonvulsants
HK1024697A (en)	2000-10-20	Substituted isoquinoline derivatives and their use as anticonvulsants
IL134499A0 (en)	2001-04-30	Pyrimidin-2- oxy-4-one and pyrimidin-2-oxy- 4-thione derivatives
ZA989113B (en)	1999-04-14	Aminobutanoic and derivatives
GB9722392D0 (en)	1997-12-24	Composition and use
GB9722023D0 (en)	1997-12-17	Levobupivacaine and its use

Legal Events

Date	Code	Title	Description
2007-12-28	FD9A	Lapse of provisional protection due to non-payment of fees